Lipoprotein disorders: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 37: | Line 37: | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |!| |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |!| |}} | ||
{{familytree | | | | | | | |,|-|-|-|-|v|-|-|-|v|-|-|-|v|-|^|-|.| | | |!| |}} | {{familytree | | | | | | | |,|-|-|-|-|v|-|-|-|v|-|-|-|v|-|^|-|.| | | |!| |}} | ||
{{familytree | | | | | | | D01 | | | D02 | | D03 | | D04 | | D05 | | D06 | D01= Type I:<br> Familial hyperchylomicronemia| D02= Type II| D03= Type III:<br>Dysbetalipoproteinemia| D04= Type IV<br> Familial hypertriglyceridemia<br>| D05= Type V: <br> Familial mixed | {{familytree | | | | | | | D01 | | | D02 | | D03 | | D04 | | D05 | | D06 | D01= Type I:<br> Familial hyperchylomicronemia| D02= Type II| D03= Type III:<br>Dysbetalipoproteinemia| D04= Type IV<br> Familial hypertriglyceridemia<br>| D05= Type V: <br> Familial mixed hypertriglycerideimia| D06= Alcoholism <br> Anorexia nervosa<br>Diabetes<br> Drugs <br>Nephrotic syndrome<br> Renal disease <br> Thyroid disease}} | ||
{{familytree | | | | | | | |!| | |,|-|^|-|.| | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | |!| | |,|-|^|-|.| | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | |!| | E01 | | E02 | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | |!| | E01 | | E02 | | | | | | | | | | | | | | | | | | | | |}} | ||
Revision as of 13:50, 10 September 2013
| Lipoprotein disorders | ||
| ICD-10 | E78 | |
|---|---|---|
| ICD-9 | 272 | |
| MeSH | C18.452.339 | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Dyslipidemia is a disruption in the amount of lipids in the blood.
In western societies, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood, often due to diet and lifestyle. The prolonged elevation of insulin levels can lead to dyslipidemia.
Classification
There are two major ways in which dyslipidemias are classified:
- Phenotype, or the presentation in the body (including the specific type of lipid that is increased)
- Etiology, or the reason for the condition (genetic, or secondary to another condition.) This classification can be problematic, because most conditions involve the intersection of genetics and lifestyle issues. However, there are a few well defined genetic conditions that are usually easy to identify.
Algorithm
| Dyslipidemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Hypolipidemia | Hyperlipidemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Familial combined hypolipidemia | Abetalipoproteinemia (Bassenn-Kornzweig syndrome) | {{{ C03 }}} | {{{ C04 }}} | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Type I: Familial hyperchylomicronemia | Type II | Type III: Dysbetalipoproteinemia | Type IV Familial hypertriglyceridemia | Type V: Familial mixed hypertriglycerideimia | Alcoholism Anorexia nervosa Diabetes Drugs Nephrotic syndrome Renal disease Thyroid disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| {{{ E01 }}} | {{{ E02 }}} | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| {{{ F01 }}} | {{{ F02 }}} | {{{ F03 }}} | {{{ F04 }}} | {{{ F05 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Types
Increases
- Hyperlipoproteinemia: lipoproteins (usually LDL unless otherwise specified)
- Hyperchylomicronemia: chylomicrons
- Combined hyperlipidemia: both LDL and triglycerides
- Familial hypercholesterolemia is a specific form of hypercholesterolemia due to a defect on chromosome 19 (19p13.1-13.3).
Decreases
- Hypolipoproteinemia: lipoproteins
- Hypocholesterolemia: cholesterol
- Abetalipoproteinemia: beta lipoproteins
- Tangier disease: high density lipoprotein